April 2022
American Academy of Neurology (AAN) 2022 Annual Meeting
Posters & Presentations
March 2022
2022 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Apitegromab in SMA: An Analysis of PK/PD Relationships to Efficacy in Ambulatory Patients from the TOPAZ Trial (#72)
January 2022
2nd Annual TGFβ for Immuno-Oncology Drug Development Summit
Development of a Comprehensive Biomarker Strategy to Support DRAGON, a Phase 1 Clinical Trial of SRK-181, the latent TGFβ1 Inhibitor (Presentation)
November 2021
36th Society for Immunotherapy of Cancer (SITC) Annual Meeting
First-in-Human Phase 1 Trial of SRK-181: A Latent TGFβ1 inhibitor, Alone or in Combination with Anti-PD-(L)1 Treatment in Patients with Advanced Solid Tumors (DRAGON trial) (#532)
October 2021
2021 World Congress of Neurology (WCN)
Relationship of Pharmacokinetics and Pharmacodynamics to Apitegromab Efficacy in Patients with Later-onset Spinal Muscular Atrophy (Types 2 and 3 SMA): Results from the TOPAZ Study (Poster #EP1150)
September 2021
2021 Child Neurology Society (CNS) Annual Meeting